期刊文献+

乳腺癌根治术后胸壁及锁骨上区放疗计划设计 被引量:3

Design of intensity modulated radiotherapy plan in chest wall and supraclavicular region for patients with breast cancer after radical mastectomy
原文传递
导出
摘要 目的 探讨乳腺癌根治术后减少呼吸运动影响、改善靶区剂量分布、尽可能降低心肺受量放疗计划的设计方法.方法 选择12例乳腺癌根治术后患者,处方剂量为50 Gy,2Gy/次,5次/周.用治疗计划系统分别设计4野调强放疗(4FIMRT)治疗计划和2野适形放疗加4野调强放疗(2FCRT+4FIMRT)混合治疗计划,比较两种计划的靶区适形度指数(CI)、均匀性指数(HI)、危及器官的受照剂量体积.结果 2FCRT+ 4FIMRT计划的HI为1.08±0.01,优于4FIMRT计划的1.11±0.01 (P<0.05);2FCRT+ 4FIMRT计划的CI为0.74±0.08,低于4FIMRT计划的0.80±0.03(P< 0.05).2FCRT+ 4FIMRT计划的同侧肺受照剂量体积V5、V10、平均剂量(Dmean)低于4FIMRT计划,同侧肺V5、V10、Dmean分别较4FIMRT计划降低了13%、23%、7%(均P<0.05).2FCRT+ 4FIMRT计划的对侧肺Dmean、心脏Dmean、对侧乳腺Dmean及V5均低于4FIMRT计划,差异均具有统计学意义(均P< 0.05).两种计划同侧肺V20、V30、心脏V30差异无统计学意义(P>0.05).结论 混合照射方式理论上减少了呼吸运动对靶区的影响,提高了靶区剂量的均匀性,降低了乳腺癌放疗并发症的发生风险。 Objective To study how to design the treatment plan to reduce the influence of respiratory movement and the dose of heart and lung as few as possible,to improve the dosage distribution in the target area after radical mastectomy of breast cancer.Methods Twelve patients with breast cancer after radical mastectomy were selected.A dose of 50 Gy with 2 Gy every day and 5 times per week was prescribed.Based on the treatment planning system (TPS),4-field intensity modulated radiotherapy (4FIMRT) and hybrid intensity modulated treatment planning 2-field conformal radiotherapy (2FCRT) + 4FIMRT were designed respectively.The two plans were compared from the aspects of target conformity index (CI),the homogeneity index (HI) and exposure dose volume delivered to organ at risk.Results According to the hybrid plan of 2FCRT + 4FIMRT,HI was 1.08±0.01,which was superior to that from 4FIMRT (1.11±0.01,t =9.587,P 〈 0.05).While CI was 0.74±0.08,based on the plan of 2FCRT+4FIMRT,which was slightly lower than that from 4FIMRT (0.80±0.03,t =2.497,P 〈 0.05).Considering the dose volumes on ipsilateral lung in two plans,the values of V5,V10,Dmean of 2FCRT+4FIMRT plan were significantly less than those of 4FIMRT plan.V5,V10,Dmean from the former plan were 13 %,23 %,7 % less than those from the latter plan (t =6.002,P 〈 0.05;t =6.826,P 〈 0.05;t =3.645,P 〈 0.05).Meanwhile,Dmean of contralateral lung,Dmean of heart,Dmean and V5 of contralateral breast from the 2FCRT +4FIMRT plan were all lower than those of 4FIMRT plan.Those differences between two plans were statistically significant (P 〈 0.05).Differences of V20 and V30 of ipsilateral lung,and V30 of heart between two plans did not make sense by the statistics analysis (P 〉 0.05).Conclusion Hybrid radiotherapy theoretically reduces the influence of respiratory movement,improves the uniformity of target dose and lowers the risk of complications of radiation therapy on breast cancer.
出处 《肿瘤研究与临床》 CAS 2015年第8期543-546,共4页 Cancer Research and Clinic
关键词 乳腺肿瘤 乳房切除术 根治性 放射疗法 调强适形 放射治疗剂量 Breast neoplasms Mastectomy,radical Radiotherapy,intensity-modulated Radiotherapy dosage
  • 相关文献

参考文献7

二级参考文献25

  • 1金大伟,戴建荣,余子豪,惠周光,王淑莲,耿辉.乳腺癌五种照射技术比较研究[J].医学研究杂志,2006,35(6):10-13. 被引量:23
  • 2谷铣之,殷蔚伯,徐国镇,等.肿瘤放射治疗学[M].北京;中国协和医科大学出版社,2002:537. 被引量:11
  • 3Schallenkamp JM, Miller RC, Brinkmann DH, et al. Incidence of radiation pneumonitis after thoracic irradiation : dose-volume correlates. Int J Radiat Oncol Biol Phys,2007 ,67 :410-416. 被引量:1
  • 4Yorke ED, Jackson A. Correlation of dosimetric factors and radiation pneumonitis for non-small cell lung cancer patients in a recently completed dose escalation study. J Radiat Oncol Biol Phys, 2005,63:672-682. 被引量:1
  • 5Gopal R, Tucker SL, Komaki R, et al. The relationship between local dose and loss of function for irradiated lung. J Radiat Oncol Biol Phys ,2003,56 : 106-113. 被引量:1
  • 6Wang S, Liao Z, Wei X, et al. Analysis of clinical an dosimetric factors associated with treatment-relatedpneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3DCRT). Int J Radiat Oncol Biol Phys,2006,66:1399-1407. 被引量:1
  • 7Sibley GS, Mundt A J, Shapiro C, et al. The treatment of stage Ⅲ non-small cell lung cancer using high dose conformal radiotherapy. Int J Radiat Oncol Biol Phys,1995,33:1001-1007. 被引量:1
  • 8Xia TY, Li HQ, Sun Qx, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage Ⅰ/Ⅱ non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 2006,66 : 117-125. 被引量:1
  • 9Bradley JD, Ieumwananonthachai N, Purdy JA, et al. Grosstumor volume,critical prognosic factor in patients treated with three-dimensional conformal radiation therapy for non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys,2002,52:49-57. 被引量:1
  • 10Bradley J, Graham MV, Winter K, et al. Toxicity and outcome resuits of RTOG 9311 : a phase Ⅰ- Ⅱ dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys, 2005,61:318-328. 被引量:1

共引文献70

同被引文献9

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部